Telix Pharmaceuticals (TLX) Current Taxes (2023 - 2026)

Telix Pharmaceuticals (TLX) has reported Current Taxes for 3 consecutive years, with $30.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Current Taxes fell 3.23% year-over-year to $30.7 million; the TTM figure through Dec 2025 stood at $30.7 million (down 3.23% YoY), while the FY2025 annual figure was $30.7 million, up 2.18% from the prior year.
• Current Taxes retreated to $30.7 million in Q4 2025 per TLX's latest filing, from $31.8 million in the prior quarter.
• Across five years, Current Taxes topped out at $31.8 million in Q4 2024 and bottomed at $12.5 million in Q4 2023.
• Historically, Current Taxes has averaged $25.0 million across 3 years, with a median of $30.7 million in 2025.
• Annual changes were most pronounced in 2024 — Current Taxes surged 154.64% — and 2025, when it retreated 3.23%.
• Telix Pharmaceuticals' Current Taxes stood at $12.5 million in 2023, then soared by 154.64% to $31.8 million in 2024, then slipped by 3.23% to $30.7 million in 2025.
• Business Quant data shows TLX's Current Taxes at $30.7 million in Q4 2025, $31.8 million in Q4 2024, and $12.5 million in Q4 2023.